Refers to: Paul Enck. Not more, but less studies are warranted-If you take your meta-analysis seriously
- PMID: 30556264
- PMCID: PMC6309196
- DOI: 10.1111/nmo.13490
Refers to: Paul Enck. Not more, but less studies are warranted-If you take your meta-analysis seriously
Abstract
This submission is in reply to a letter by Dr. Paul Enck regarding our recent conclusions regarding the clinical efficacy of patented probiotic, VSL#3, in Irritable Bowel Syndrome.
Comment on
-
Systematic review and meta-analysis: Efficacy of patented probiotic, VSL#3, in irritable bowel syndrome.Neurogastroenterol Motil. 2018 Dec;30(12):e13427. doi: 10.1111/nmo.13427. Epub 2018 Aug 1. Neurogastroenterol Motil. 2018. PMID: 30069978 Free PMC article.
-
Not more, but less studies are warranted-If you take your meta-analysis seriously.Neurogastroenterol Motil. 2019 Jan;31(1):e13473. doi: 10.1111/nmo.13473. Neurogastroenterol Motil. 2019. PMID: 30556262 No abstract available.
References
-
- Ford AC, Quigley EM, Lacy BE, et al. Efficacy of prebiotics, probiotics, and synbiotics in irritable bowel syndrome and chronic idiopathic constipation: systematic review and meta-analysis. Am J Gastroenterol 2014;109:1547–61; quiz 1546, 1562. - PubMed
-
- Staudacher HM, Lomer MCE, Farquharson FM, et al. A Diet Low in FODMAPs Reduces Symptoms in Patients With Irritable Bowel Syndrome and A Probiotic Restores Bifidobacterium Species: A Randomized Controlled Trial. Gastroenterology 2017;153:936–947. - PubMed
-
- Kim HJ, Camilleri M, McKinzie S, et al. A randomized controlled trial of a probiotic, VSL#3, on gut transit and symptoms in diarrhoea-predominant irritable bowel syndrome. Aliment Pharmacol Ther 2003;17:895–904. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
